Studying paclitaxel to see how well it works compared to polyglutamate paclitaxel or observation only in treating patients
This randomized phase III trial studies paclitaxel to see how well it works compared to polyglutamate paclitaxel or observation only in treating patients with stage III or stage IV ovarian epithelial, peritoneal cancer, or fallopian tube cancer. Drugs used in chemotherapy, such as paclitaxel and polyglutamate paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Paclitaxel and polyglutamate paclitaxel may also stop the growth of ovarian epithelial or peritoneal cancer by blocking blood flow to the tumor. Sometimes, after treatment, the tumor may not need additional treatment until it progresses. In this case, observation may be sufficient. It is not yet known whether paclitaxel is more effective than polyglutamate paclitaxel or observation only in treating ovarian epithelial, peritoneal, or fallopian tube cancer.
This research study is led by Dr. Tashanna Myers.
Contact: Laura Sorci, 413-794-3188
March 21, 2005
Baystate Medical Center, 759 Chestnut St, Springfield, MA
Ages Eligible for Study: Child, Adult, Older Adult
Sexes Eligible for Study: Female
Accepts Healthy Volunteers: No
Interventional (Clinical Trial), Randomized